Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-105768)

Filing Details

Accession Number:: 0001104659-20-105768
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-16 18:31:22
Reporting Period:: 2020-09-14

Accepted Time:: 2020-09-16 18:31:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1442836	Mersana Therapeutics Inc.	MRSN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1709771	M. Eva Jack	C/O Mersana Therapeutics, Inc. 840 Memorial Drive Cambridge MA 02139	Chief Bus. Officer, Tres, Sec.	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-14	35,248	$1.53	35,248	No	4	M	Direct
Common Stock	Disposition	2020-09-14	35,248	$22.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-09-14	35,248	$0.00	35,248	$1.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
35,248		2025-11-06	No	4	M	Direct

Footnotes

The stock option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 7, 2020.
The options vested in equal quarterly installments over the first four years after the vesting commencement date, June 12, 2015.